Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lung Neoplasms 7Prostatic Neoplasms 6Hematopoietic and Lymphatic System Neoplasm 6Hematologic Neoplasms 6Colorectal Neoplasms 5Breast Neoplasms 5Anatomic Stage I Breast Cancer AJCC v8 5Pancreatic Neoplasms 3Neoplasms 3Malignant Solid Neoplasm 3Leukemia, Myeloid, Acute 3Urinary Bladder Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Mouth Neoplasms 2Melanoma 2Head and Neck Carcinoma 2Glioma 2Carcinoma, Renal Cell 2Carcinoma 2COVID-19 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urologic Diseases 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Tonsillar Neoplasms 1Tongue Neoplasms 1Teratoma 1

Interventions

Cyclophosphamide 5Specimen Handling 4Magnetic Resonance Spectroscopy 4Biopsy 4Nivolumab 3sodium-iodide symporter 2fludarabine 2cemiplimab 2X-Rays 2Whole-Body Irradiation 2Stem Cell Transplantation 2Photons 2Mycophenolic Acid 2Immunoglobulin G 2Disulfides 2Cyclosporine 210-propargyl-10-deazaaminopterin 2treosulfan 1talimogene laherparepvec 1sargramostim 1ruxolitinib 1pembrolizumab 1fludarabine phosphate 1entrectinib 1duvelisib 1ceritinib 1belinostat 1alectinib 1Vincristine 1Vinblastine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Large-Cell, Anaplastic × Practice Guidelines as Topic × 90 days × Clear all
NCT06724237 2026-05-15

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Eastern Cooperative Oncology Group

Phase 3 Recruiting
294 enrolled
Lymphoid

Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡